Model
Edge
Five Prime Therapeutics, Inc.
0001175505
Filing type
4
Filing date
Apr 18, 2021
Updated
Apr 19, 2021 ยท 1:32 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership